Comparison of Local Features from Two Spanish Hospitals Reveals Common and Specific Traits at Multiple Levels of the Molecular Epidemiology of Metallo-β-Lactamase-Producing Pseudomonas spp | Zendy

Esther Viedma | Zendy; Vanesa Estepa | Zendy; Carlos Juan | Zendy; Jane Castillo-Vera | Zendy; Beatriz RojoBezares | Zendy; Cristina Seral | Zendy; Francisco Javier Castillo | Zendy; Yolanda Sáenz | Zendy; Cármen Torres | Zendy; Fernando Cháves | Zendy; Antonio Oliver | Zendy

Open Access

Comparison of Local Features from Two Spanish Hospitals Reveals Common and Specific Traits at Multiple Levels of the Molecular Epidemiology of Metallo-β-Lactamase-Producing Pseudomonas spp

Author(s) -

Esther Viedma,

Vanesa Estepa,

Carlos Juan,

Jane Castillo-Vera,

Beatriz RojoBezares,

Cristina Seral,

Francisco Javier Castillo,

Yolanda Sáenz,

Cármen Torres,

Fernando Cháves,

Antonio Oliver

Publication year - 2014

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.02586-13

Subject(s) - epidemiology , pseudomonas , biology , molecular epidemiology , pseudomonas aeruginosa , microbiology and biotechnology , genetics , bacteria , medicine , genotype , gene

Twenty-seven well-characterized metallo-β-lactamase (MBL)-producingPseudomonas strains from two distantly located hospitals were analyzed. The results revealed specific features defining the multilevel epidemiology of strains from each hospital in terms of species, clonality, predominance of high-risk clones, composition/diversity of integrons, and linkages of Tn402 -related structures. Therefore, despite the global trends driving the epidemiology of MBL-producingPseudomonas spp., the presence of local features has to be considered in order to understand this threat and implement proper control strategies.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research